| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 1.40e-09 | 372 | 76 | 13 | GO:0061630 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 3.16e-09 | 398 | 76 | 13 | GO:0061659 |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 2.46e-08 | 473 | 76 | 13 | GO:0004842 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 6.22e-08 | 512 | 76 | 13 | GO:0019787 |
| GeneOntologyMolecularFunction | cadmium ion binding | 9.37e-08 | 12 | 76 | 4 | GO:0046870 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 9.70e-08 | 532 | 76 | 13 | GO:0016755 |
| GeneOntologyMolecularFunction | zinc ion binding | UBR1 UBR2 MT1F MT1G MT1H MT1M MT1X MT2A RNF31 ZGRF1 RNPEPL1 MIB1 ANAPC11 UBR3 TRIM27 TRIM23 | 1.89e-07 | 891 | 76 | 16 | GO:0008270 |
| GeneOntologyMolecularFunction | acyltransferase activity | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 PJA1 BRD1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 1.15e-06 | 775 | 76 | 14 | GO:0016746 |
| GeneOntologyMolecularFunction | transition metal ion binding | UBR1 UBR2 MT1F MT1G MT1H MT1M MT1X MT2A RNF31 ZGRF1 RNPEPL1 MIB1 ANAPC11 UBR3 PLSCR3 TRIM27 TRIM23 | 1.79e-06 | 1189 | 76 | 17 | GO:0046914 |
| GeneOntologyMolecularFunction | copper ion binding | 1.19e-05 | 78 | 76 | 5 | GO:0005507 | |
| GeneOntologyMolecularFunction | histone H3K27 trimethyltransferase activity | 4.28e-05 | 3 | 76 | 2 | GO:0140951 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 4.91e-05 | 19 | 76 | 3 | GO:0005520 | |
| GeneOntologyMolecularFunction | histone H3K27 methyltransferase activity | 2.12e-04 | 6 | 76 | 2 | GO:0046976 | |
| GeneOntologyMolecularFunction | L-leucine binding | 2.97e-04 | 7 | 76 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.23e-04 | 156 | 76 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | insulin-like growth factor II binding | 3.94e-04 | 8 | 76 | 2 | GO:0031995 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 5.06e-04 | 9 | 76 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor 2 binding | 6.31e-04 | 10 | 76 | 2 | GO:0043184 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 7.69e-04 | 11 | 76 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 7.69e-04 | 11 | 76 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 9.21e-04 | 12 | 76 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 9.68e-04 | 51 | 76 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 1.09e-03 | 13 | 76 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 1.14e-03 | 54 | 76 | 3 | GO:0042056 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.45e-03 | 15 | 76 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.81e-03 | 229 | 76 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor binding | 1.87e-03 | 17 | 76 | 2 | GO:0005172 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor binding | 1.87e-03 | 17 | 76 | 2 | GO:0005161 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 3.43e-03 | 23 | 76 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 5.07e-03 | 28 | 76 | 2 | GO:0140326 | |
| GeneOntologyBiologicalProcess | detoxification of copper ion | 1.47e-11 | 16 | 75 | 6 | GO:0010273 | |
| GeneOntologyBiologicalProcess | stress response to copper ion | 1.47e-11 | 16 | 75 | 6 | GO:1990169 | |
| GeneOntologyBiologicalProcess | cellular response to chromate | 3.08e-11 | 8 | 75 | 5 | GO:0071247 | |
| GeneOntologyBiologicalProcess | response to chromate | 6.91e-11 | 9 | 75 | 5 | GO:0046687 | |
| GeneOntologyBiologicalProcess | nitric oxide mediated signal transduction | 1.07e-10 | 40 | 75 | 7 | GO:0007263 | |
| GeneOntologyBiologicalProcess | stress response to metal ion | 1.34e-10 | 22 | 75 | 6 | GO:0097501 | |
| GeneOntologyBiologicalProcess | detoxification of inorganic compound | 3.16e-10 | 25 | 75 | 6 | GO:0061687 | |
| GeneOntologyBiologicalProcess | cellular response to copper ion | 5.25e-10 | 27 | 75 | 6 | GO:0071280 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | 6.66e-10 | 28 | 75 | 6 | GO:0071294 | |
| GeneOntologyBiologicalProcess | cellular response to cadmium ion | 1.03e-08 | 43 | 75 | 6 | GO:0071276 | |
| GeneOntologyBiologicalProcess | response to copper ion | 1.03e-08 | 43 | 75 | 6 | GO:0046688 | |
| GeneOntologyBiologicalProcess | intracellular zinc ion homeostasis | 1.19e-08 | 44 | 75 | 6 | GO:0006882 | |
| GeneOntologyBiologicalProcess | response to zinc ion | 8.93e-08 | 61 | 75 | 6 | GO:0010043 | |
| GeneOntologyBiologicalProcess | response to cadmium ion | 1.73e-07 | 68 | 75 | 6 | GO:0046686 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 1.84e-07 | 4 | 75 | 3 | GO:0071596 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 8.64e-07 | 283 | 75 | 9 | GO:0045926 | |
| GeneOntologyBiologicalProcess | detoxification | 2.83e-06 | 170 | 75 | 7 | GO:0098754 | |
| GeneOntologyBiologicalProcess | regulation of growth | MT1F MT1G MT1H MT1M MT1X MT2A IGFBP1 IGFBP5 IGFBP7 JADE2 SLIT1 PLAC8 VEGFA | 4.07e-06 | 777 | 75 | 13 | GO:0040008 |
| GeneOntologyBiologicalProcess | protein polyubiquitination | 1.01e-05 | 289 | 75 | 8 | GO:0000209 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 1.01e-05 | 289 | 75 | 8 | GO:0009636 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 1.49e-05 | 219 | 75 | 7 | GO:0071248 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 3.37e-05 | 811 | 75 | 12 | GO:0016567 |
| GeneOntologyBiologicalProcess | positive regulation of autophagy | 3.98e-05 | 173 | 75 | 6 | GO:0010508 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 4.78e-05 | 55 | 75 | 4 | GO:0045332 | |
| GeneOntologyBiologicalProcess | lipid translocation | 6.74e-05 | 60 | 75 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 8.51e-05 | 893 | 75 | 12 | GO:0032446 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 9.23e-05 | 65 | 75 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | regulation of autophagy | 1.01e-04 | 400 | 75 | 8 | GO:0010506 | |
| GeneOntologyBiologicalProcess | response to metal ion | 1.30e-04 | 415 | 75 | 8 | GO:0010038 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron apoptotic process | 2.19e-04 | 236 | 75 | 6 | GO:0043524 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 2.66e-04 | 1009 | 75 | 12 | GO:0070647 |
| GeneOntologyBiologicalProcess | positive regulation of mast cell chemotaxis | 2.71e-04 | 7 | 75 | 2 | GO:0060754 | |
| GeneOntologyBiologicalProcess | embryo implantation | 4.33e-04 | 97 | 75 | 4 | GO:0007566 | |
| GeneOntologyBiologicalProcess | regulation of mast cell chemotaxis | 4.62e-04 | 9 | 75 | 2 | GO:0060753 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 4.67e-04 | 177 | 75 | 5 | GO:0071229 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | UBR1 UBR2 RNF31 JADE2 MIB1 ANAPC11 UBR3 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 4.68e-04 | 1074 | 75 | 12 | GO:0043687 |
| GeneOntologyBiologicalProcess | growth | MT1F MT1G MT1H MT1M MT1X MT2A IGFBP1 IGFBP5 IGFBP7 JADE2 SLIT1 PLAC8 VEGFA | 4.68e-04 | 1235 | 75 | 13 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of viral process | 5.85e-04 | 186 | 75 | 5 | GO:0050792 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 6.05e-04 | 106 | 75 | 4 | GO:0015914 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | GPR155 UBR1 UBR2 HGF MT1F MT1G MT1H MT1M MT1X IGFBP1 IGFBP5 PLSCR3 PTGS2 DNMT3A | 6.56e-04 | 1450 | 75 | 14 | GO:1901701 |
| GeneOntologyBiologicalProcess | regulation of p38MAPK cascade | 8.98e-04 | 52 | 75 | 3 | GO:1900744 | |
| GeneOntologyBiologicalProcess | cellular response to L-leucine | 9.92e-04 | 13 | 75 | 2 | GO:0071233 | |
| GeneOntologyBiologicalProcess | regulation of viral entry into host cell | 1.06e-03 | 55 | 75 | 3 | GO:0046596 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical NF-kappaB signal transduction | 1.08e-03 | 213 | 75 | 5 | GO:0043123 | |
| GeneOntologyCellularComponent | lysosome | GPR155 HSPG2 MT1F MT1G MT1H MT1M MT1X ATP11B MIOS PLAC8 TRIM23 | 1.42e-04 | 811 | 75 | 11 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | GPR155 HSPG2 MT1F MT1G MT1H MT1M MT1X ATP11B MIOS PLAC8 TRIM23 | 1.42e-04 | 811 | 75 | 11 | GO:0000323 |
| GeneOntologyCellularComponent | female germ cell nucleus | 1.85e-04 | 31 | 75 | 3 | GO:0001674 | |
| GeneOntologyCellularComponent | growth factor complex | 3.51e-04 | 8 | 75 | 2 | GO:0036454 | |
| GeneOntologyCellularComponent | vacuole | GPR155 HSPG2 MT1F MT1G MT1H MT1M MT1X ATP11B MIOS PLAC8 TRIM23 | 3.94e-04 | 913 | 75 | 11 | GO:0005773 |
| Domain | Metalthion_vert_metal_BS | 7.09e-13 | 10 | 75 | 6 | IPR018064 | |
| Domain | Metalthion_dom_vert | 3.10e-12 | 12 | 75 | 6 | IPR023587 | |
| Domain | Metalthion_dom | 3.10e-12 | 12 | 75 | 6 | IPR017854 | |
| Domain | - | 3.10e-12 | 12 | 75 | 6 | 4.10.10.10 | |
| Domain | METALLOTHIONEIN_VRT | 5.74e-12 | 13 | 75 | 6 | PS00203 | |
| Domain | Metalthion_vert | 1.00e-11 | 14 | 75 | 6 | IPR000006 | |
| Domain | Metalthion | 1.00e-11 | 14 | 75 | 6 | IPR003019 | |
| Domain | Metallothio | 1.00e-11 | 14 | 75 | 6 | PF00131 | |
| Domain | Znf_RING | UBR1 UBR2 RNF31 MIB1 ANAPC11 UBR3 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 NSD3 | 5.27e-10 | 326 | 75 | 13 | IPR001841 |
| Domain | ZF_RING_2 | UBR1 UBR2 RNF31 MIB1 ANAPC11 UBR3 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 2.33e-09 | 298 | 75 | 12 | PS50089 |
| Domain | - | UBR1 UBR2 JADE2 MIB1 ANAPC11 UBR3 PJA1 BRD1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 NSD3 | 2.59e-09 | 449 | 75 | 14 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | UBR1 UBR2 JADE2 MIB1 ANAPC11 UBR3 PJA1 BRD1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 NSD3 | 3.43e-09 | 459 | 75 | 14 | IPR013083 |
| Domain | ZF_RING_1 | UBR1 UBR2 RNF31 MIB1 UBR3 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 | 2.20e-08 | 291 | 75 | 11 | PS00518 |
| Domain | RING | UBR2 RNF31 MIB1 ANAPC11 PJA1 TRIM27 RFPL1 RFPL3 RFPL2 TRIM23 NSD3 | 3.56e-08 | 305 | 75 | 11 | SM00184 |
| Domain | Growth_fac_rcpt_ | 2.08e-07 | 156 | 75 | 8 | IPR009030 | |
| Domain | RDM | 6.18e-07 | 5 | 75 | 3 | PF11002 | |
| Domain | RDM_domain_RFPL | 6.18e-07 | 5 | 75 | 3 | IPR022723 | |
| Domain | ZF_UBR | 2.15e-06 | 7 | 75 | 3 | PS51157 | |
| Domain | zf-UBR | 2.15e-06 | 7 | 75 | 3 | PF02207 | |
| Domain | Znf_UBR | 2.15e-06 | 7 | 75 | 3 | IPR003126 | |
| Domain | ZnF_UBR1 | 2.15e-06 | 7 | 75 | 3 | SM00396 | |
| Domain | zf-C3HC4 | 3.09e-06 | 223 | 75 | 8 | PF00097 | |
| Domain | ClpS_core | 1.59e-05 | 2 | 75 | 2 | IPR003769 | |
| Domain | FAM24 | 1.59e-05 | 2 | 75 | 2 | PF15193 | |
| Domain | Med13_N | 1.59e-05 | 2 | 75 | 2 | PF11597 | |
| Domain | ClpS | 1.59e-05 | 2 | 75 | 2 | PF02617 | |
| Domain | Mediator_Med13_N_met/fun | 1.59e-05 | 2 | 75 | 2 | IPR021643 | |
| Domain | Mediator_Med13 | 1.59e-05 | 2 | 75 | 2 | IPR009401 | |
| Domain | FAM24 | 1.59e-05 | 2 | 75 | 2 | IPR028122 | |
| Domain | Med13_C | 1.59e-05 | 2 | 75 | 2 | PF06333 | |
| Domain | PRY | 2.39e-05 | 42 | 75 | 4 | PF13765 | |
| Domain | PRY | 4.08e-05 | 48 | 75 | 4 | SM00589 | |
| Domain | PRY | 4.08e-05 | 48 | 75 | 4 | IPR006574 | |
| Domain | EGF | 4.38e-05 | 235 | 75 | 7 | SM00181 | |
| Domain | Ribosomal_L7/12_C/ClpS-like | 4.76e-05 | 3 | 75 | 2 | IPR014719 | |
| Domain | PLAC_motif_containing | 4.76e-05 | 3 | 75 | 2 | IPR006461 | |
| Domain | - | 4.76e-05 | 3 | 75 | 2 | 3.30.1390.10 | |
| Domain | PLAC8 | 4.76e-05 | 3 | 75 | 2 | PF04749 | |
| Domain | IB | 4.86e-05 | 18 | 75 | 3 | SM00121 | |
| Domain | IGFBP-like | 6.75e-05 | 20 | 75 | 3 | IPR000867 | |
| Domain | IGFBP | 6.75e-05 | 20 | 75 | 3 | PF00219 | |
| Domain | IGFBP_N_2 | 6.75e-05 | 20 | 75 | 3 | PS51323 | |
| Domain | PWWP | 6.75e-05 | 20 | 75 | 3 | SM00293 | |
| Domain | EGF_1 | 7.33e-05 | 255 | 75 | 7 | PS00022 | |
| Domain | EGF_2 | 9.33e-05 | 265 | 75 | 7 | PS01186 | |
| Domain | PWWP | 1.04e-04 | 23 | 75 | 3 | PF00855 | |
| Domain | PWWP_dom | 1.04e-04 | 23 | 75 | 3 | IPR000313 | |
| Domain | PWWP | 1.18e-04 | 24 | 75 | 3 | PS50812 | |
| Domain | EGF | 1.53e-04 | 126 | 75 | 5 | PF00008 | |
| Domain | Butyrophylin | 1.80e-04 | 70 | 75 | 4 | IPR003879 | |
| Domain | IGFBP1-6 | 2.36e-04 | 6 | 75 | 2 | IPR009168 | |
| Domain | IGFBP_1-6_chordata | 2.36e-04 | 6 | 75 | 2 | IPR022321 | |
| Domain | ConA-like_dom | 2.49e-04 | 219 | 75 | 6 | IPR013320 | |
| Domain | PD_growth_factor_CS | 3.30e-04 | 7 | 75 | 2 | IPR023581 | |
| Domain | EGF_3 | 3.63e-04 | 235 | 75 | 6 | PS50026 | |
| Domain | SPRY | 4.15e-04 | 87 | 75 | 4 | SM00449 | |
| Domain | EPL1 | 4.39e-04 | 8 | 75 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 4.39e-04 | 8 | 75 | 2 | IPR019542 | |
| Domain | EGF-like_dom | 4.94e-04 | 249 | 75 | 6 | IPR000742 | |
| Domain | SPRY | 5.57e-04 | 94 | 75 | 4 | PF00622 | |
| Domain | SPRY_dom | 5.57e-04 | 94 | 75 | 4 | IPR003877 | |
| Domain | PDGF | 5.62e-04 | 9 | 75 | 2 | PF00341 | |
| Domain | PDGF_2 | 5.62e-04 | 9 | 75 | 2 | PS50278 | |
| Domain | PDGF_1 | 5.62e-04 | 9 | 75 | 2 | PS00249 | |
| Domain | PDGF/VEGF_dom | 5.62e-04 | 9 | 75 | 2 | IPR000072 | |
| Domain | PDGF | 5.62e-04 | 9 | 75 | 2 | SM00141 | |
| Domain | B30.2/SPRY | 5.79e-04 | 95 | 75 | 4 | IPR001870 | |
| Domain | B302_SPRY | 5.79e-04 | 95 | 75 | 4 | PS50188 | |
| Domain | EGF-like_CS | 6.32e-04 | 261 | 75 | 6 | IPR013032 | |
| Domain | Insulin_GF-bd_Cys-rich_CS | 8.55e-04 | 11 | 75 | 2 | IPR017891 | |
| Domain | IGFBP_N_1 | 1.02e-03 | 12 | 75 | 2 | PS00222 | |
| Domain | P_typ_ATPase_c | 1.40e-03 | 14 | 75 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.40e-03 | 14 | 75 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.40e-03 | 14 | 75 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.40e-03 | 14 | 75 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.40e-03 | 14 | 75 | 2 | PF16209 | |
| Domain | EGF_extracell | 1.81e-03 | 60 | 75 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.81e-03 | 60 | 75 | 3 | PF07974 | |
| Domain | Disintegrin_CS | 1.84e-03 | 16 | 75 | 2 | IPR018358 | |
| Domain | TY | 2.08e-03 | 17 | 75 | 2 | SM00211 | |
| Domain | - | 2.08e-03 | 17 | 75 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_2 | 2.08e-03 | 17 | 75 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 2.08e-03 | 17 | 75 | 2 | IPR000716 | |
| Domain | Thyroglobulin_1 | 2.08e-03 | 17 | 75 | 2 | PF00086 | |
| Domain | THYROGLOBULIN_1_1 | 2.08e-03 | 17 | 75 | 2 | PS00484 | |
| Domain | Zinc_finger_PHD-type_CS | 2.27e-03 | 65 | 75 | 3 | IPR019786 | |
| Domain | ADAM_CR | 2.34e-03 | 18 | 75 | 2 | PF08516 | |
| Domain | - | 2.88e-03 | 20 | 75 | 2 | 4.10.70.10 | |
| Domain | Znf_FYVE_PHD | 2.90e-03 | 147 | 75 | 4 | IPR011011 | |
| Domain | Disintegrin | 3.18e-03 | 21 | 75 | 2 | PF00200 | |
| Domain | DISIN | 3.18e-03 | 21 | 75 | 2 | SM00050 | |
| Domain | PHD | 3.41e-03 | 75 | 75 | 3 | PF00628 | |
| Domain | EPHD | 3.49e-03 | 22 | 75 | 2 | PS51805 | |
| Domain | WAP_dom | 3.49e-03 | 22 | 75 | 2 | IPR008197 | |
| Domain | Znf_PHD-finger | 3.95e-03 | 79 | 75 | 3 | IPR019787 | |
| Pathway | REACTOME_METALLOTHIONEINS_BIND_METALS | 1.52e-12 | 11 | 57 | 6 | M27543 | |
| Pathway | REACTOME_RESPONSE_TO_METAL_IONS | 9.76e-12 | 14 | 57 | 6 | M27541 | |
| Pathway | WP_ZINC_HOMEOSTASIS | 7.04e-09 | 37 | 57 | 6 | M39377 | |
| Pathway | WP_OXIDATIVE_STRESS_RESPONSE | 3.09e-07 | 36 | 57 | 5 | MM15941 | |
| Pathway | WP_LUNG_FIBROSIS | 4.61e-07 | 73 | 57 | 6 | MM15827 | |
| Pathway | WP_COPPER_HOMEOSTASIS | 2.24e-06 | 53 | 57 | 5 | M39349 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 2.85e-06 | 25 | 57 | 4 | M118 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | MT1F MT1G MT1H MT1M MT1X MT2A IGFBP1 IGFBP7 MIOS ANAPC11 EXOSC5 VEGFA | 9.49e-05 | 828 | 57 | 12 | M27827 |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 2.60e-04 | 31 | 57 | 3 | MM15818 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY | 4.43e-04 | 8 | 57 | 2 | M47513 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 4.43e-04 | 8 | 57 | 2 | M710 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 4.43e-04 | 8 | 57 | 2 | MM14753 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING | 4.78e-04 | 38 | 57 | 3 | M39707 | |
| Pathway | PID_VEGF_VEGFR_PATHWAY | 7.08e-04 | 10 | 57 | 2 | M137 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 1779826 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 21913972 | ||
| Pubmed | Gene expression profiles in the liver and kidney of metallothionein-null mice. | 8.06e-15 | 9 | 77 | 6 | 15913548 | |
| Pubmed | Atrophy of large myelinated axons in metallothionein-I, II knockout mice. | 8.06e-15 | 9 | 77 | 6 | 16133945 | |
| Pubmed | Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. | 8.06e-15 | 9 | 77 | 6 | 16936113 | |
| Pubmed | Decreased neurofilament density in large myelinated axons of metallothionein-I, II knockout mice. | 8.06e-15 | 9 | 77 | 6 | 16600496 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 17031522 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 8619230 | ||
| Pubmed | Distribution and retention of cadmium in metallothionein I and II null mice. | 8.06e-15 | 9 | 77 | 6 | 8619234 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 15071173 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 11160536 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 12122050 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 12700403 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 16432836 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10947810 | ||
| Pubmed | Metallothionein regulates intracellular zinc signaling during CD4(+) T cell activation. | 8.06e-15 | 9 | 77 | 6 | 27251638 | |
| Pubmed | Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. | 8.06e-15 | 9 | 77 | 6 | 9512723 | |
| Pubmed | Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice. | 8.06e-15 | 9 | 77 | 6 | 23967274 | |
| Pubmed | Cadmium-induced mRNA expression of Hsp32 is augmented in metallothionein-I and -II knock-out mice. | 8.06e-15 | 9 | 77 | 6 | 11051100 | |
| Pubmed | Sensitivity of metallothionein-null mice to LPS/D-galactosamine-induced lethality. | 8.06e-15 | 9 | 77 | 6 | 11162523 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 25761970 | ||
| Pubmed | Metallothionein-null mice express altered genes during development. | 8.06e-15 | 9 | 77 | 6 | 10753647 | |
| Pubmed | Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. | 8.06e-15 | 9 | 77 | 6 | 11835189 | |
| Pubmed | Deficiency of metallothionein-1 and -2 genes shortens the lifespan of the 129/Sv mouse strain. | 8.06e-15 | 9 | 77 | 6 | 25871729 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 2303527 | ||
| Pubmed | Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. | 8.06e-15 | 9 | 77 | 6 | 8683339 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 8367468 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 11585628 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10788577 | ||
| Pubmed | Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity. | 8.06e-15 | 9 | 77 | 6 | 10966523 | |
| Pubmed | Impaired hepatic regeneration in metallothionein-I/II knockout mice after partial hepatectomy. | 8.06e-15 | 9 | 77 | 6 | 15618127 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 16563532 | ||
| Pubmed | Antioxidant status in the liver of hypertensive and metallothionein-deficient mice. | 8.06e-15 | 9 | 77 | 6 | 14608409 | |
| Pubmed | Increased radiation-induced apoptosis in mouse thymus in the absence of metallothionein. | 8.06e-15 | 9 | 77 | 6 | 10413187 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 9125117 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 28426713 | ||
| Pubmed | Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice. | 8.06e-15 | 9 | 77 | 6 | 10426817 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 9176863 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 26267326 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 19828842 | ||
| Pubmed | Mercury-induced cognitive impairment in metallothionein-1/2 null mice. | 8.06e-15 | 9 | 77 | 6 | 18226494 | |
| Pubmed | The role of metallothionein in a dinitrofluorobenzene-induced atopic dermatitis-like murine model. | 8.06e-15 | 9 | 77 | 6 | 30042397 | |
| Pubmed | Metallothionein blocks oxidative DNA damage induced by acute inorganic arsenic exposure. | 8.06e-15 | 9 | 77 | 6 | 25485709 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 19837066 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10764993 | ||
| Pubmed | Development of a compartmental model of zinc kinetics in mice. | 8.06e-15 | 9 | 77 | 6 | 18936212 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 20144643 | ||
| Pubmed | Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity. | 8.06e-15 | 9 | 77 | 6 | 17910954 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 14692620 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 11298796 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 23880315 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 22363575 | ||
| Pubmed | Augmented humoral immune function in metallothionein-null mice. | 8.06e-15 | 9 | 77 | 6 | 10906280 | |
| Pubmed | Metallothionein expression and neurocognitive function in mice. | 8.06e-15 | 9 | 77 | 6 | 16430929 | |
| Pubmed | Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. | 8.06e-15 | 9 | 77 | 6 | 10087053 | |
| Pubmed | CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. | 8.06e-15 | 9 | 77 | 6 | 10087067 | |
| Pubmed | Helicobacter-induced gastritis in mice not expressing metallothionein-I and II. | 8.06e-15 | 9 | 77 | 6 | 14536000 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10736338 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10460198 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10869470 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 17624681 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 30557628 | ||
| Pubmed | Epidermal proliferation of the skin in metallothionein-null mice. | 8.06e-15 | 9 | 77 | 6 | 9506445 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 19254786 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 17409522 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 15520181 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10099782 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 15979673 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 15306638 | ||
| Pubmed | Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice. | 8.06e-15 | 9 | 77 | 6 | 8615771 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 18579766 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 18239062 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 24138881 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 16126615 | ||
| Pubmed | Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength. | 8.06e-15 | 9 | 77 | 6 | 27956698 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 11950277 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 23467591 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 2576352 | ||
| Pubmed | Nitric-oxide-mediated zinc release contributes to hypoxic regulation of pulmonary vascular tone. | 8.06e-15 | 9 | 77 | 6 | 18483408 | |
| Pubmed | Development of high-fat-diet-induced obesity in female metallothionein-null mice. | 8.06e-15 | 9 | 77 | 6 | 20219986 | |
| Pubmed | Metallothionein-induced zinc partitioning exacerbates hyperoxic acute lung injury. | 8.06e-15 | 9 | 77 | 6 | 23275622 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 16049321 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10505629 | ||
| Pubmed | Down-regulation of metallothionein 1 and 2 after exposure to electromagnetic field in mouse testis. | 8.06e-15 | 9 | 77 | 6 | 22395140 | |
| Pubmed | Metallothionein deficiency aggravates depleted uranium-induced nephrotoxicity. | 8.06e-15 | 9 | 77 | 6 | 26148447 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 2019319 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 16150881 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 18083145 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 35454172 | ||
| Pubmed | Distribution and retention of mercury in metallothionen-null mice after exposure to mercury vapor. | 8.06e-15 | 9 | 77 | 6 | 10614694 | |
| Pubmed | Using MT(-/-) mice to study metallothionein and oxidative stress. | 8.06e-15 | 9 | 77 | 6 | 10699757 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 10495773 | ||
| Pubmed | Mammalian MT1 and MT2 metallothioneins differ in their metal binding abilities. | 8.06e-15 | 9 | 77 | 6 | 23925449 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 15161632 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 14499492 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 11891201 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 15735556 | ||
| Pubmed | Cytoprotection by metallothionein against gastroduodenal mucosal injury caused by ethanol in mice. | 8.06e-15 | 9 | 77 | 6 | 10744072 | |
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 12613667 | ||
| Pubmed | 8.06e-15 | 9 | 77 | 6 | 20798270 | ||
| Interaction | IGF2 interactions | 5.09e-07 | 42 | 76 | 5 | int:IGF2 | |
| Interaction | UBE2D2 interactions | 3.05e-06 | 318 | 76 | 9 | int:UBE2D2 | |
| Interaction | DKK4 interactions | 6.07e-06 | 10 | 76 | 3 | int:DKK4 | |
| Interaction | MT1M interactions | 4.04e-05 | 18 | 76 | 3 | int:MT1M | |
| Interaction | SPINK7 interactions | 4.78e-05 | 19 | 76 | 3 | int:SPINK7 | |
| Interaction | CIMIP4 interactions | 4.78e-05 | 19 | 76 | 3 | int:CIMIP4 | |
| Interaction | RFPL3 interactions | 5.61e-05 | 20 | 76 | 3 | int:RFPL3 | |
| Interaction | RFPL2 interactions | 7.54e-05 | 22 | 76 | 3 | int:RFPL2 | |
| Interaction | GCC2-AS1 interactions | 8.38e-05 | 4 | 76 | 2 | int:GCC2-AS1 | |
| Interaction | UBE2Z interactions | 1.06e-04 | 65 | 76 | 4 | int:UBE2Z | |
| Interaction | UBE2D1 interactions | 1.21e-04 | 294 | 76 | 7 | int:UBE2D1 | |
| Interaction | IGF1 interactions | 1.41e-04 | 27 | 76 | 3 | int:IGF1 | |
| Cytoband | 16q13 | 3.41e-11 | 36 | 77 | 6 | 16q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q13 | 6.69e-11 | 40 | 77 | 6 | chr16q13 | |
| Cytoband | 1p36.3 | 2.49e-04 | 14 | 77 | 2 | 1p36.3 | |
| Cytoband | 8p11.2 | 2.49e-04 | 14 | 77 | 2 | 8p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p11 | 7.11e-04 | 103 | 77 | 3 | chr8p11 | |
| Cytoband | 22q12.3 | 1.42e-03 | 33 | 77 | 2 | 22q12.3 | |
| Cytoband | 10q26.13 | 1.88e-03 | 38 | 77 | 2 | 10q26.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p12 | 5.08e-03 | 63 | 77 | 2 | chr7p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q26 | 5.17e-03 | 207 | 77 | 3 | chr10q26 | |
| GeneFamily | Metallothioneins | 1.25e-11 | 19 | 53 | 6 | 638 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 8.26e-07 | 7 | 53 | 3 | 785 | |
| GeneFamily | PWWP domain containing | 3.52e-05 | 22 | 53 | 3 | 1147 | |
| GeneFamily | VEGF family | 8.38e-05 | 5 | 53 | 2 | 1267 | |
| GeneFamily | Insulin like growth factor binding proteins | 1.26e-04 | 6 | 53 | 2 | 1065 | |
| GeneFamily | Ring finger proteins | 1.48e-04 | 275 | 53 | 6 | 58 | |
| GeneFamily | ATPase phospholipid transporting | 8.64e-04 | 15 | 53 | 2 | 1210 | |
| GeneFamily | PHD finger proteins | 2.33e-03 | 90 | 53 | 3 | 88 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.82e-03 | 27 | 53 | 2 | 47 | |
| GeneFamily | Cyclins|Mediator complex | 4.20e-03 | 33 | 53 | 2 | 1061 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.45e-03 | 34 | 53 | 2 | 487 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.17e-02 | 161 | 53 | 3 | 593 | |
| Coexpression | RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP | 1.47e-14 | 8 | 77 | 6 | M41082 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP | 3.79e-11 | 22 | 77 | 6 | MM1299 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP | 9.55e-11 | 48 | 77 | 7 | MM649 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 1.48e-10 | 27 | 77 | 6 | MM643 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 4.31e-10 | 59 | 77 | 7 | MM952 | |
| Coexpression | ZHENG_RESPONSE_TO_ARSENITE_UP | 5.63e-10 | 15 | 77 | 5 | M1589 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | CSRNP1 MT1F MT1G MT1H MT1M MT1X MT2A TSPAN13 KCNN4 SKIL ITGB5 | 1.13e-09 | 297 | 77 | 11 | MM1003 |
| Coexpression | BUSSLINGER_DUODENAL_BCHE_CELLS | 2.95e-09 | 43 | 77 | 6 | M40032 | |
| Coexpression | HOUSTIS_ROS | 3.40e-09 | 44 | 77 | 6 | MM1142 | |
| Coexpression | WU_CELL_MIGRATION | 3.47e-09 | 183 | 77 | 9 | M2001 | |
| Coexpression | MA_RAT_AGING_UP | 3.87e-09 | 127 | 77 | 8 | MM16096 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 4.94e-09 | 131 | 77 | 8 | MM1127 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | CSRNP1 MT1F MT1G MT1H MT1M MT1X MT2A ATP11B UPP1 MED13L PTGS2 NSD3 | 5.21e-09 | 435 | 77 | 12 | MM1221 |
| Coexpression | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP | 6.19e-09 | 23 | 77 | 5 | MM1198 | |
| Coexpression | PIONTEK_PKD1_TARGETS_UP | 8.54e-09 | 51 | 77 | 6 | MM794 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 1.22e-08 | 54 | 77 | 6 | MM715 | |
| Coexpression | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN | 1.22e-08 | 54 | 77 | 6 | MM1195 | |
| Coexpression | ZHANG_UTERUS_C2_REGENERATIVE_UP | 1.49e-08 | 97 | 77 | 7 | MM16605 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP | 1.79e-08 | 28 | 77 | 5 | MM487 | |
| Coexpression | LUDWICZEK_TREATING_IRON_OVERLOAD | 3.35e-08 | 12 | 77 | 4 | MM792 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_ENDOTHELIAL_CELL_AGEING | CSRNP1 MT1F MT1G MT1H MT1M MT1X MT2A IGFBP5 UPP1 PTGS2 VEGFA | 3.87e-08 | 418 | 77 | 11 | MM3681 |
| Coexpression | BRACHAT_RESPONSE_TO_METHOTREXATE_DN | 8.92e-08 | 38 | 77 | 5 | MM1161 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 9.12e-08 | 126 | 77 | 7 | MM3711 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN | PPP4R1 MT1F MT1G MT1H MDFIC MT1X MT2A IGFBP7 UPP1 TWSG1 PTGS2 | 9.53e-08 | 457 | 77 | 11 | M14507 |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP | 1.02e-07 | 128 | 77 | 7 | M15887 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP | 1.22e-07 | 16 | 77 | 4 | MM1089 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN | 1.29e-07 | 199 | 77 | 8 | M9920 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN | 1.34e-07 | 200 | 77 | 8 | M7595 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 1.54e-07 | 136 | 77 | 7 | MM3747 | |
| Coexpression | MA_MYELOID_DIFFERENTIATION_UP | 2.39e-07 | 46 | 77 | 5 | MM640 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP | 3.28e-07 | 93 | 77 | 6 | MM850 | |
| Coexpression | GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN | 3.28e-07 | 93 | 77 | 6 | MM1149 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 3.64e-07 | 228 | 77 | 8 | MM3676 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_UP | 4.47e-07 | 52 | 77 | 5 | MM628 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_VENTRICULAR_ZONE | 4.47e-07 | 52 | 77 | 5 | MM442 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 5.05e-07 | 100 | 77 | 6 | MM514 | |
| Coexpression | PILON_KLF1_TARGETS_UP | MT1F MT1G MT1H MT1M MT1X IGFBP1 IGFBP7 MIB1 MIOS ADAM12 MED13 | 5.11e-07 | 541 | 77 | 11 | MM1061 |
| Coexpression | CSR_LATE_UP.V1_UP | 5.96e-07 | 166 | 77 | 7 | M2660 | |
| Coexpression | JIANG_AGING_HYPOTHALAMUS_UP | 7.78e-07 | 58 | 77 | 5 | MM703 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_HMOX1_POS_PRIMITIVE_ERYTHROBLAST | 8.31e-07 | 25 | 77 | 4 | M45753 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 8.84e-07 | 176 | 77 | 7 | MM1048 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 9.35e-07 | 111 | 77 | 6 | MM705 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 1.20e-06 | 267 | 77 | 8 | MM1091 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP | 1.23e-06 | 185 | 77 | 7 | MM1115 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP | 1.34e-06 | 28 | 77 | 4 | MM707 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 1.45e-06 | 274 | 77 | 8 | M289 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP | 1.69e-06 | 194 | 77 | 7 | M5852 | |
| Coexpression | KAN_RESPONSE_TO_ARSENIC_TRIOXIDE | 1.71e-06 | 123 | 77 | 6 | M1784 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 1.81e-06 | 196 | 77 | 7 | MM3746 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 1.87e-06 | 125 | 77 | 6 | MM1065 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP | 2.01e-06 | 199 | 77 | 7 | M9915 | |
| Coexpression | GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN | 2.08e-06 | 200 | 77 | 7 | M4459 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 3.33e-06 | 138 | 77 | 6 | MM1047 | |
| Coexpression | AIZARANI_LIVER_C14_HEPATOCYTES_2 | 4.65e-06 | 226 | 77 | 7 | M39118 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 4.94e-06 | 84 | 77 | 5 | MM873 | |
| Coexpression | SASAKI_TARGETS_OF_TP73_AND_TP63 | 5.26e-06 | 12 | 77 | 3 | M17374 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_CELL_AGEING | 6.00e-06 | 332 | 77 | 8 | MM3679 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ACINAR_CELLS | 6.94e-06 | 90 | 77 | 5 | M40267 | |
| Coexpression | NABA_MATRISOME | HGF HSPG2 FRAS1 IGFBP1 IGFBP5 MEGF6 IGFBP7 SLIT1 ADAM2 CPN2 VEGFD ADAM12 VEGFA | 6.98e-06 | 1008 | 77 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | HGF HSPG2 FRAS1 IGFBP1 IGFBP5 MEGF6 IGFBP7 SLIT1 ADAM2 CPN2 VEGFD ADAM12 VEGFA | 8.44e-06 | 1026 | 77 | 13 | M5889 |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_DN | 9.00e-06 | 250 | 77 | 7 | M10117 | |
| Coexpression | NEMETH_INFLAMMATORY_RESPONSE_LPS_UP | 1.11e-05 | 99 | 77 | 5 | MM1152 | |
| Coexpression | CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP | 1.28e-05 | 102 | 77 | 5 | M12300 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.29e-05 | 369 | 77 | 8 | MM16610 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP | 1.30e-05 | 175 | 77 | 6 | MM501 | |
| Coexpression | GHANDHI_DIRECT_IRRADIATION_UP | 1.47e-05 | 105 | 77 | 5 | M2591 | |
| Coexpression | TABULA_MURIS_SENIS_DIAPHRAGM_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 1.48e-05 | 270 | 77 | 7 | MM3696 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 1.52e-05 | 271 | 77 | 7 | MM1075 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 1.84e-05 | 186 | 77 | 6 | MM498 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN | 1.91e-05 | 281 | 77 | 7 | M7089 | |
| Coexpression | SUNG_METASTASIS_STROMA_DN | 1.95e-05 | 54 | 77 | 4 | M2904 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS | 1.95e-05 | 188 | 77 | 6 | M40287 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | 1.96e-05 | 391 | 77 | 8 | M41659 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | 2.01e-05 | 112 | 77 | 5 | MM1095 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | 2.19e-05 | 287 | 77 | 7 | M6510 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE | 2.19e-05 | 114 | 77 | 5 | M45759 | |
| Coexpression | BUSSLINGER_GASTRIC_CHIEF_CELLS | 2.25e-05 | 56 | 77 | 4 | M40006 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.33e-05 | 194 | 77 | 6 | M39122 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN | 2.47e-05 | 196 | 77 | 6 | M8003 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP | 2.47e-05 | 196 | 77 | 6 | M10014 | |
| Coexpression | GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 2.62e-05 | 198 | 77 | 6 | M4462 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP | 2.69e-05 | 199 | 77 | 6 | M8105 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP | 2.69e-05 | 199 | 77 | 6 | M7951 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 2.69e-05 | 199 | 77 | 6 | M5264 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | UBR2 MT1X IGFBP1 UPP1 MED13L BRD1 EZH1 SKIL PTGS2 TRIM23 VEGFA | 2.73e-05 | 822 | 77 | 11 | M6782 |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 2.77e-05 | 200 | 77 | 6 | M9909 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN | 2.77e-05 | 200 | 77 | 6 | M8735 | |
| Coexpression | AIZARANI_LIVER_C11_HEPATOCYTES_1 | 2.79e-05 | 298 | 77 | 7 | M39115 | |
| Coexpression | SAUL_SEN_MAYO | 3.16e-05 | 123 | 77 | 5 | MM16098 | |
| Coexpression | SAUL_SEN_MAYO | 3.29e-05 | 124 | 77 | 5 | M45803 | |
| Coexpression | NAKAMURA_ADIPOGENESIS_EARLY_UP | 3.60e-05 | 63 | 77 | 4 | M2024 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MACROPHAGE_AGEING | 3.83e-05 | 128 | 77 | 5 | MM3838 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 3.83e-05 | 212 | 77 | 6 | MM3816 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_B_CELL_AGEING | 3.97e-05 | 315 | 77 | 7 | MM3784 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 4.13e-05 | 317 | 77 | 7 | MM956 | |
| Coexpression | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN | 4.38e-05 | 320 | 77 | 7 | M8582 | |
| Coexpression | NADLER_OBESITY_UP | 4.59e-05 | 67 | 77 | 4 | MM1007 | |
| Coexpression | AMUNDSON_RESPONSE_TO_ARSENITE | 4.59e-05 | 219 | 77 | 6 | M262 | |
| Coexpression | BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP | 5.35e-05 | 25 | 77 | 3 | M15908 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN | 5.45e-05 | 70 | 77 | 4 | MM994 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OS-NL-Confounder_removed-fold2.0_adjp0.05 | 3.33e-07 | 78 | 75 | 6 | PCBC_ratio_ESC_vs_iPSC_method-OS-NL_cfr-2X-p05 | |
| CoexpressionAtlas | SC blastocyst_vs_SC fibroblast-Confounder_removed-fold2.0_adjp0.05 | 3.50e-06 | 9 | 75 | 3 | PCBC_ratio_SC blastocyst_vs_SC fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 4.42e-06 | 455 | 75 | 10 | GSM777055_500 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_NA_vs_Endoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 1.92e-05 | 45 | 75 | 4 | PCBC_ratio_DE_from-ESC_vs_DE_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_NA_vs_Endoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 1.92e-05 | 45 | 75 | 4 | PCBC_ratio_DE_from-ESC_vs_DE_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO amniotic fluid MSC_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 4.64e-05 | 183 | 75 | 6 | PCBC_ratio_ECTO amniotic fluid MSC_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | SC-LF blastocyst_vs_SC blastocyst-Confounder_removed-fold2.0_adjp0.05 | 7.33e-05 | 393 | 75 | 8 | PCBC_ratio_SC-LF blastocyst_vs_SC blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PPP4R1 HGF IGFBP5 IGFBP7 PJA1 SKIL VEGFD ADAM12 ITGB5 DNMT3A VEGFA | 7.66e-05 | 768 | 75 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | HGF FRAS1 IGFBP5 IGFBP7 ZGRF1 PJA1 VEGFD ADAM12 ITGB5 DNMT3A VEGFA | 8.49e-05 | 777 | 75 | 11 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.68e-04 | 146 | 75 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.36e-04 | 466 | 75 | 8 | GSM777050_500 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.72e-13 | 179 | 77 | 10 | 0e22e840f43ca81a7543dcf33ec17a741cdf7f37 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.72e-13 | 179 | 77 | 10 | 17ba1eedb6ebf039d3b11d099351d0ac6363c8d1 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.72e-13 | 179 | 77 | 10 | 7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.72e-13 | 179 | 77 | 10 | a20bb3ace5be10c5aef330e9268c0ba55f8fee23 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_Inf._Macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.84e-12 | 198 | 77 | 10 | ebc064dede536eda7715af0675fd4e657ff4ac5d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-09 | 188 | 77 | 8 | d00f48afed62fc60d3530bb3b80ac0162b0b0ed8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-09 | 190 | 77 | 8 | ad0d9aed8c9c99551765d14730d70ebef1ea856b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-09 | 191 | 77 | 8 | 7065728128e37572b87e6b024374796bd2172e92 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-09 | 191 | 77 | 8 | 7717cf1d99b4451d7145d91367637895f9a2c1c3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-09 | 192 | 77 | 8 | 4a2c82e7af700ae6f04742027877768b151f5d81 | |
| ToppCell | Macrophages-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-09 | 194 | 77 | 8 | cbb1c65ccee58b2892f7d3fa45773099411c6104 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.06e-09 | 199 | 77 | 8 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-09 | 199 | 77 | 8 | c4a1e0cf3be867e7cebbd8bd3668bc2df391671b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-08 | 173 | 77 | 7 | 021457c7bdb55de7351e43322d360e8fd7061658 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-08 | 181 | 77 | 7 | 1c04e53f46992a0aea9d3eee985681ec4e71f80d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-08 | 181 | 77 | 7 | a8d4b2340d99734bf9379b467fb481c598b9b4fb | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-08 | 181 | 77 | 7 | 83adf61f44cebe9e75de175c5dc39237fbf9ed24 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-08 | 184 | 77 | 7 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-08 | 184 | 77 | 7 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-08 | 185 | 77 | 7 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.35e-08 | 185 | 77 | 7 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.47e-08 | 186 | 77 | 7 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-08 | 187 | 77 | 7 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class （2021.01.30） | 3.60e-08 | 187 | 77 | 7 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-08 | 187 | 77 | 7 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.60e-08 | 187 | 77 | 7 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.60e-08 | 187 | 77 | 7 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.60e-08 | 187 | 77 | 7 | 0d589de12108230ced5b60229564f4a181e2f172 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.74e-08 | 188 | 77 | 7 | 5d6faf45a9c0794b0c30b0a0601c10afbb8aa9ed | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.74e-08 | 188 | 77 | 7 | a0873783f0a2cd852563c05a275dddc72905ced2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-08 | 188 | 77 | 7 | e7f58cd67afac441204c29676de2ffa7aaafd988 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.74e-08 | 188 | 77 | 7 | 29d804232d974a8c0029300345b287005b09bade | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-08 | 188 | 77 | 7 | 1a751452c0f1f34b3c20fad2fb52c378ab2d0207 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Non-resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.02e-08 | 190 | 77 | 7 | 4fe9654a9b449ef49ca10b973ac4378dab34cb53 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.47e-08 | 193 | 77 | 7 | a313541cedfcff8fb311b9bc60157359aa103830 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-08 | 195 | 77 | 7 | 7ff04c45a02df01e3816f3c1d43585a93182a730 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-08 | 195 | 77 | 7 | 09605533aa5947bb2e5a6725c1ce89f79d330bf5 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.33e-08 | 198 | 77 | 7 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.33e-08 | 198 | 77 | 7 | 36a60397f49f5381ae377155b73e1891448846b7 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.33e-08 | 198 | 77 | 7 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-08 | 199 | 77 | 7 | fb9550bbb1fa206c3132e0a21a646eedb41c281a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-08 | 199 | 77 | 7 | 440f47e320c75f49ef47139b46962de68cee8320 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.51e-08 | 199 | 77 | 7 | e09bd3153dd60d06584707b259c78375b47415c8 | |
| ToppCell | background|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.51e-08 | 199 | 77 | 7 | 5a6d0e00bfe1351eea192b54020bedeef78854e9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-08 | 199 | 77 | 7 | 8efa724d47b95194d42907ffae17284c3953605e | |
| ToppCell | COVID-19-kidney-PCT-S3-1|kidney / Disease (COVID-19 only), tissue and cell type | 5.51e-08 | 199 | 77 | 7 | 3e6cfc3c0b2edce0d51db9de80e38f724e6c0cb8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-08 | 199 | 77 | 7 | fd1a9f9ab5eeb8c50005304715bb0f35b7926935 | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.71e-08 | 200 | 77 | 7 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-07 | 169 | 77 | 6 | 1dfaf9a6b433a5ee86a11962af188978c2543278 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-07 | 169 | 77 | 6 | 3e267ec9f884df326315500dfd751b04a3dd91bd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-07 | 171 | 77 | 6 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-07 | 171 | 77 | 6 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-07 | 171 | 77 | 6 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-07 | 171 | 77 | 6 | f2b31c97bbcc5164fc279ed0362007878887ad5e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-07 | 171 | 77 | 6 | 3a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.99e-07 | 175 | 77 | 6 | b227d4499274fb63b193d34de7f2d812e283e79d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.99e-07 | 175 | 77 | 6 | 308ee4ef7b9ecea68efca011ef91aed0f1be0eca | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.20e-07 | 176 | 77 | 6 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 6.20e-07 | 176 | 77 | 6 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.20e-07 | 176 | 77 | 6 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Primitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.84e-07 | 179 | 77 | 6 | 3c8046f43da5a02fa4278a7175b9cd8cf95b8e27 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-07 | 180 | 77 | 6 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-07 | 180 | 77 | 6 | 271ee52ed8f21f78ddf68e52fc88fe582701675e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-07 | 180 | 77 | 6 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-07 | 180 | 77 | 6 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.30e-07 | 181 | 77 | 6 | bec917f6f56ae252639a5a76024be5df5c70a6d5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.54e-07 | 182 | 77 | 6 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | wk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.78e-07 | 183 | 77 | 6 | 7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.29e-07 | 185 | 77 | 6 | c3d1a312569f3d619f7295812741cbf068ec6c1f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.56e-07 | 186 | 77 | 6 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-07 | 187 | 77 | 6 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.83e-07 | 187 | 77 | 6 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-07 | 187 | 77 | 6 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-07 | 187 | 77 | 6 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-07 | 187 | 77 | 6 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-07 | 187 | 77 | 6 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-07 | 190 | 77 | 6 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.69e-07 | 190 | 77 | 6 | e950f40d578c1eec8c6030cf1cb51823eac24bc7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-07 | 190 | 77 | 6 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.69e-07 | 190 | 77 | 6 | ab56800abd1d5cbe2351834a1df749ac7db30892 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.99e-07 | 191 | 77 | 6 | dd73173a898e29624acb22dd783339f3e696a213 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.99e-07 | 191 | 77 | 6 | bd0f8adfb2a508babee73477d0e9300330471e7a | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.99e-07 | 191 | 77 | 6 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.99e-07 | 191 | 77 | 6 | 674e7a27b5f736f14f8513e5ef0d56e4e746d989 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.99e-07 | 191 | 77 | 6 | 84c3ccc819fb5acec68daab2e6cc65d5d8909cc4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 192 | 77 | 6 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.03e-06 | 192 | 77 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-06 | 192 | 77 | 6 | f345b269c8cf06b004bc9419462dbc69bffaab89 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-06 | 192 | 77 | 6 | 1a3d95a9801cc4569b67fa652b2af46c4dedbaef | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-06 | 192 | 77 | 6 | 9946f5d5cab64936ca68d9f4dc9ce6eba85b43ab | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 192 | 77 | 6 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 192 | 77 | 6 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-06 | 194 | 77 | 6 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-06 | 194 | 77 | 6 | 64e07de047969017628a164b254852c87d33844c | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-06 | 195 | 77 | 6 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-06 | 195 | 77 | 6 | 9c24ebce2e3e00b8b692c62a22a53b7d59f0eabb | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-06 | 195 | 77 | 6 | e1fb987f13482d1fce0428413244be3621136424 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-06 | 195 | 77 | 6 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-06 | 195 | 77 | 6 | 482a2e7db72f0da285bb658943dd668777519734 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-06 | 195 | 77 | 6 | 1a4a5623fa0318ef388cc228c7060e0586a7acf9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.21e-06 | 50 | 50 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.21e-06 | 50 | 50 | 5 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.21e-06 | 50 | 50 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE | |
| Computational | IGFBPs. | 2.02e-05 | 12 | 50 | 3 | MODULE_190 | |
| Computational | Genes in the cancer module 474. | 6.15e-05 | 17 | 50 | 3 | MODULE_474 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.15e-05 | 50 | 50 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.15e-05 | 50 | 50 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.15e-05 | 50 | 50 | 4 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_V_ATPASE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-03 | 50 | 50 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes in the cancer module 321. | 1.78e-03 | 112 | 50 | 4 | MODULE_321 | |
| Computational | Genes in the cancer module 470. | 2.44e-03 | 16 | 50 | 2 | MODULE_470 | |
| Drug | Disperse Blue 7 | 3.00e-11 | 61 | 77 | 8 | CID000018514 | |
| Drug | Organoselenium Compounds | 1.06e-10 | 71 | 77 | 8 | ctd:D016566 | |
| Drug | MeOBGDTC | 1.76e-10 | 11 | 77 | 5 | CID000119173 | |
| Drug | alpha-mercapto-beta-(2-furyl)acrylic acid | 4.89e-10 | 13 | 77 | 5 | CID006437871 | |
| Drug | diamsar | 7.58e-10 | 14 | 77 | 5 | CID000146286 | |
| Drug | Cadmium-thionein | 7.58e-10 | 14 | 77 | 5 | CID000198548 | |
| Drug | urs-12-ene-3beta,28-diol | 1.13e-09 | 15 | 77 | 5 | CID000092802 | |
| Drug | MT45 | 1.13e-09 | 15 | 77 | 5 | CID000431865 | |
| Drug | tolmetin glucuronide | 2.32e-09 | 17 | 77 | 5 | ctd:C056583 | |
| Drug | azelaic bishydroxamic acid | 2.32e-09 | 17 | 77 | 5 | CID000065268 | |
| Drug | ZnATP | 2.32e-09 | 17 | 77 | 5 | CID006455240 | |
| Drug | bismuth nitrate | 2.32e-09 | 17 | 77 | 5 | CID000107711 | |
| Drug | zomepirac glucuronide | 3.21e-09 | 18 | 77 | 5 | ctd:C027368 | |
| Drug | AC1O3QMZ | 4.34e-09 | 19 | 77 | 5 | CID006334573 | |
| Drug | cadmium oxide | 7.56e-09 | 21 | 77 | 5 | CID000014782 | |
| Drug | AC1L45V9 | 9.00e-09 | 45 | 77 | 6 | CID000151205 | |
| Drug | 4-(2-pyridylazo)resorcinol | 9.76e-09 | 22 | 77 | 5 | CID005370169 | |
| Drug | zinc hydroxide | 9.76e-09 | 22 | 77 | 5 | CID000062742 | |
| Drug | manganese sulfate monohydrate | 1.24e-08 | 23 | 77 | 5 | CID000166832 | |
| Drug | hinokitiol | 1.95e-08 | 25 | 77 | 5 | CID000003611 | |
| Drug | auranofin | 2.21e-08 | 52 | 77 | 6 | CID006918453 | |
| Drug | MT20 | 2.41e-08 | 26 | 77 | 5 | CID003025942 | |
| Drug | BGDTC | 2.41e-08 | 26 | 77 | 5 | CID000105107 | |
| Drug | Oral-Turinabol | 2.95e-08 | 27 | 77 | 5 | CID000098521 | |
| Drug | tetrathiomolybdate | 5.88e-08 | 61 | 77 | 6 | CID005245480 | |
| Drug | Ormaplatino | 6.15e-08 | 31 | 77 | 5 | CID006434704 | |
| Drug | alpha-hederin | 7.27e-08 | 32 | 77 | 5 | CID000073296 | |
| Drug | Zinquin | 8.55e-08 | 33 | 77 | 5 | CID000132933 | |
| Drug | rhodanine | 9.99e-08 | 34 | 77 | 5 | CID001201546 | |
| Drug | L-beta-aspartyl phosphate | 1.24e-07 | 69 | 77 | 6 | CID000000832 | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A | 1.33e-07 | 174 | 77 | 8 | 2456_UP | |
| Drug | p-hydroxyphenyllactic acid | 1.35e-07 | 36 | 77 | 5 | CID000009378 | |
| Drug | PCI 5002 | UBR2 CSRNP1 MT1F MT1G MT1H MT1M MT1X MT2A MIB1 MED13L SKIL VEGFD DISP1 VEGFA | 1.51e-07 | 735 | 77 | 14 | ctd:C568608 |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.52e-07 | 177 | 77 | 8 | 6463_UP | |
| Drug | ursolic acid | 1.61e-07 | 72 | 77 | 6 | CID000064945 | |
| Drug | genistin | 1.78e-07 | 38 | 77 | 5 | CID005281377 | |
| Drug | arsenic(III | 2.33e-07 | 40 | 77 | 5 | CID000104734 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.51e-07 | 189 | 77 | 8 | 3408_UP | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 2.51e-07 | 189 | 77 | 8 | 3084_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; HL60; HG-U133A | 2.51e-07 | 189 | 77 | 8 | 1369_UP | |
| Drug | bismuth | 2.99e-07 | 42 | 77 | 5 | CID000105143 | |
| Drug | trans-DDP | 3.80e-07 | 44 | 77 | 5 | CID000084691 | |
| Drug | trien | 4.77e-07 | 46 | 77 | 5 | CID000005565 | |
| Drug | midodrine | 5.32e-07 | 47 | 77 | 5 | CID000004195 | |
| Drug | octachloronaphthalene | 5.32e-07 | 47 | 77 | 5 | CID000016692 | |
| Drug | dimercaprol | 5.93e-07 | 48 | 77 | 5 | CID000003080 | |
| Drug | DL-propargylglycine | 5.93e-07 | 48 | 77 | 5 | CID000095575 | |
| Drug | elesclomol | 6.58e-07 | 49 | 77 | 5 | ctd:C512195 | |
| Drug | dimethylmercury | 8.90e-07 | 52 | 77 | 5 | CID000011645 | |
| Drug | oleanolic acid | 8.90e-07 | 52 | 77 | 5 | CID000010494 | |
| Drug | p-terphenyl | 1.35e-06 | 103 | 77 | 6 | CID000007115 | |
| Drug | Zinc Acetate | 1.51e-06 | 166 | 77 | 7 | ctd:D019345 | |
| Drug | Hydrocortisone | 1.57e-06 | 167 | 77 | 7 | ctd:D006854 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.70e-06 | 169 | 77 | 7 | 5724_UP | |
| Drug | ZnSO4.7H2O | 2.34e-06 | 63 | 77 | 5 | CID000062639 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.41e-06 | 178 | 77 | 7 | 2048_UP | |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | 2.59e-06 | 180 | 77 | 7 | 2410_UP | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; HL60; HT_HG-U133A | 2.79e-06 | 182 | 77 | 7 | 2576_UP | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.89e-06 | 183 | 77 | 7 | 3480_UP | |
| Drug | dicarboxymethyldithiocarbamate | 3.08e-06 | 9 | 77 | 3 | CID000130472 | |
| Drug | CAPSO-DTC | 3.08e-06 | 9 | 77 | 3 | CID003081023 | |
| Drug | NiCl2 | 3.15e-06 | 119 | 77 | 6 | CID000024385 | |
| Drug | zinc sulfate | 3.68e-06 | 69 | 77 | 5 | CID000024424 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; HL60; HG-U133A | 4.25e-06 | 194 | 77 | 7 | 1364_UP | |
| Drug | PmMT | 4.39e-06 | 10 | 77 | 3 | CID000085248 | |
| Drug | 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine | 4.39e-06 | 10 | 77 | 3 | CID000819992 | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.40e-06 | 195 | 77 | 7 | 6247_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; HL60; HT_HG-U133A | 4.40e-06 | 195 | 77 | 7 | 2189_UP | |
| Drug | fluoroacetic acid | 4.55e-06 | 72 | 77 | 5 | CID000005236 | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.55e-06 | 196 | 77 | 7 | 3305_UP | |
| Drug | Fe-NTA | 4.87e-06 | 73 | 77 | 5 | CID000027880 | |
| Drug | zinc chloride | 5.20e-06 | 378 | 77 | 9 | ctd:C016837 | |
| Drug | CAP-N-DTC | 6.02e-06 | 11 | 77 | 3 | CID000125337 | |
| Drug | selenium | 7.65e-06 | 80 | 77 | 5 | CID006326970 | |
| Drug | motexafin gadolinium | 1.02e-05 | 146 | 77 | 6 | ctd:C437683 | |
| Drug | single bond | 1.13e-05 | 2 | 77 | 2 | ctd:C115612 | |
| Drug | acetylbetulinic acid | 1.22e-05 | 88 | 77 | 5 | CID000289984 | |
| Drug | NSC236997 | 1.35e-05 | 539 | 77 | 10 | CID000005300 | |
| Drug | CuSO4 | 1.52e-05 | 92 | 77 | 5 | CID000024462 | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.55e-05 | 157 | 77 | 6 | 2651_UP | |
| Drug | S-nitrosocysteine | 1.60e-05 | 93 | 77 | 5 | CID003359494 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.72e-05 | 160 | 77 | 6 | 2210_UP | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.72e-05 | 160 | 77 | 6 | 1297_UP | |
| Drug | Prenylamine lactate [69-43-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.78e-05 | 161 | 77 | 6 | 2886_UP | |
| Drug | calmidazolium chloride; Up 200; 5uM; MCF7; HG-U133A | 2.05e-05 | 165 | 77 | 6 | 486_UP | |
| Drug | rutin | 2.06e-05 | 98 | 77 | 5 | CID005280805 | |
| Drug | CdCl2 | 2.06e-05 | 98 | 77 | 5 | CID000024947 | |
| Drug | 5224221; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 2.12e-05 | 166 | 77 | 6 | 956_UP | |
| Drug | TPEN | 2.27e-05 | 100 | 77 | 5 | CID000005519 | |
| Drug | diethyldithiocarbamate | 2.38e-05 | 101 | 77 | 5 | CID000008987 | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.43e-05 | 170 | 77 | 6 | 5021_UP | |
| Drug | Arsenites | 2.44e-05 | 17 | 77 | 3 | ctd:D018053 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.51e-05 | 171 | 77 | 6 | 3318_UP | |
| Drug | silver nanoparticles | 2.59e-05 | 172 | 77 | 6 | CID000023954 | |
| Drug | 4-aminophenylarsenoxide | 2.66e-05 | 355 | 77 | 8 | ctd:C032642 | |
| Drug | bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV) | 2.75e-05 | 104 | 77 | 5 | ctd:C551172 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.77e-05 | 174 | 77 | 6 | 5613_UP | |
| Drug | fluconazole | 3.15e-05 | 107 | 77 | 5 | CID000003365 | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; HL60; HT_HG-U133A | 3.24e-05 | 179 | 77 | 6 | 2928_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.24e-05 | 179 | 77 | 6 | 6210_UP | |
| Disease | retinitis pigmentosa (biomarker_via_orthology) | 3.91e-06 | 13 | 72 | 3 | DOID:10584 (biomarker_via_orthology) | |
| Disease | median neuropathy (biomarker_via_orthology) | 4.97e-06 | 14 | 72 | 3 | DOID:571 (biomarker_via_orthology) | |
| Disease | adult-onset Still's disease (is_marker_for) | 5.87e-06 | 2 | 72 | 2 | DOID:14256 (is_marker_for) | |
| Disease | kidney failure (biomarker_via_orthology) | 1.31e-05 | 19 | 72 | 3 | DOID:1074 (biomarker_via_orthology) | |
| Disease | Clear-cell metastatic renal cell carcinoma | 3.51e-05 | 4 | 72 | 2 | C2931852 | |
| Disease | inverted papilloma (is_marker_for) | 3.51e-05 | 4 | 72 | 2 | DOID:3179 (is_marker_for) | |
| Disease | retinitis pigmentosa (is_marker_for) | 3.51e-05 | 4 | 72 | 2 | DOID:10584 (is_marker_for) | |
| Disease | retinopathy of prematurity (is_marker_for) | 8.75e-05 | 6 | 72 | 2 | DOID:13025 (is_marker_for) | |
| Disease | Neoplasm Recurrence, Local | 1.20e-04 | 39 | 72 | 3 | C0027643 | |
| Disease | Polyomavirus Infections | 1.22e-04 | 7 | 72 | 2 | C0949804 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 1.84e-04 | 45 | 72 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 2.23e-04 | 121 | 72 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | cholesteatoma (is_marker_for) | 2.61e-04 | 10 | 72 | 2 | DOID:869 (is_marker_for) | |
| Disease | systemic scleroderma (is_marker_for) | 2.99e-04 | 53 | 72 | 3 | DOID:418 (is_marker_for) | |
| Disease | prostatitis (biomarker_via_orthology) | 3.81e-04 | 12 | 72 | 2 | DOID:14654 (biomarker_via_orthology) | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 3.90e-04 | 58 | 72 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | diabetic angiopathy (is_implicated_in) | 4.50e-04 | 13 | 72 | 2 | DOID:11713 (is_implicated_in) | |
| Disease | diabetic neuropathy (is_implicated_in) | 5.24e-04 | 14 | 72 | 2 | DOID:9743 (is_implicated_in) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 5.24e-04 | 14 | 72 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Alobar Holoprosencephaly | 6.04e-04 | 15 | 72 | 2 | C0431363 | |
| Disease | Lobar Holoprosencephaly | 6.89e-04 | 16 | 72 | 2 | C0431362 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 6.89e-04 | 16 | 72 | 2 | C4551479 | |
| Disease | Semilobar Holoprosencephaly | 6.89e-04 | 16 | 72 | 2 | C0751617 | |
| Disease | Barrett Epithelium | 6.89e-04 | 16 | 72 | 2 | C1258085 | |
| Disease | Spondyloepiphyseal Dysplasia | 6.89e-04 | 16 | 72 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 6.89e-04 | 16 | 72 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 6.89e-04 | 16 | 72 | 2 | C0025237 | |
| Disease | Barrett Esophagus | 6.89e-04 | 16 | 72 | 2 | C0004763 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 6.89e-04 | 16 | 72 | 2 | C3541456 | |
| Disease | Holoprosencephaly | 7.80e-04 | 17 | 72 | 2 | C0079541 | |
| Disease | Van Buchem disease | 7.80e-04 | 17 | 72 | 2 | C0432272 | |
| Disease | Gastric ulcer | 8.76e-04 | 18 | 72 | 2 | C0038358 | |
| Disease | carotid artery disease (is_marker_for) | 9.77e-04 | 19 | 72 | 2 | DOID:3407 (is_marker_for) | |
| Disease | Dyschondroplasias | 9.77e-04 | 19 | 72 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 9.77e-04 | 19 | 72 | 2 | C0029422 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.08e-03 | 20 | 72 | 2 | C0026760 | |
| Disease | cardiovascular system disease (is_implicated_in) | 1.20e-03 | 21 | 72 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | Respiratory Hypersensitivity | 1.31e-03 | 22 | 72 | 2 | C0035228 | |
| Disease | Reperfusion Injury | 1.36e-03 | 89 | 72 | 3 | C0035126 | |
| Disease | Liver carcinoma | 1.50e-03 | 507 | 72 | 6 | C2239176 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.57e-03 | 24 | 72 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | myocardial infarction (is_implicated_in) | 1.85e-03 | 99 | 72 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | Liver Cirrhosis | 2.07e-03 | 103 | 72 | 3 | C0023890 | |
| Disease | osteoarthritis (is_implicated_in) | 2.13e-03 | 28 | 72 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | Fibrosis, Liver | 2.19e-03 | 105 | 72 | 3 | C0239946 | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 2.28e-03 | 29 | 72 | 2 | DOID:332 (is_marker_for) | |
| Disease | urinary bladder cancer (is_marker_for) | 2.31e-03 | 107 | 72 | 3 | DOID:11054 (is_marker_for) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.37e-03 | 108 | 72 | 3 | DOID:684 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CRPGEGNCSCCKECM | 46 | Q9GZX9 | |
| GCCSVFCALAMVLCD | 241 | Q4AC99 | |
| VCCICMDGECQNSNV | 216 | O95696 | |
| ENCGICRMAFNGCCP | 21 | Q9NYG5 | |
| CRMAFNGCCPDCKVP | 26 | Q9NYG5 | |
| PCPMGCDCFVQEVFC | 21 | P22792 | |
| CFSALGMVQCCKVTC | 246 | Q400G9 | |
| VLMCGNNNCCRCFCV | 546 | Q9Y6K1 | |
| NCAEGPCCENCLFMS | 426 | Q99965 | |
| GEPEECMNRCCNATT | 441 | O43184 | |
| FFQCMCRCLGPQGTC | 1126 | Q96F81 | |
| SCQQMGDCLCHQCSP | 1286 | Q96F81 | |
| MDPNCSCTTGVSCAC | 1 | Q8N339 | |
| GCLPCFCMGITQQCA | 1321 | P98160 | |
| VCKACHSSCLACMGP | 651 | Q86XX4 | |
| CCICACNMNIKGADV | 1131 | Q71F56 | |
| VCLCTGVMGVCCTAL | 266 | O15554 | |
| CCCCGDEMGDDCNCP | 201 | Q9P1T7 | |
| DCLEICMECCGICFP | 231 | Q9P1T7 | |
| CLPCPEGCTSCMDAT | 356 | Q6PRD1 | |
| MDHTAFPCGCCREGC | 261 | Q96S65 | |
| SCCSCSMGNGELHCP | 591 | Q7Z3F1 | |
| ECTGTCIQCSMPSCV | 316 | Q9NQC1 | |
| LHCGCSCCPCGLQEM | 156 | Q9NRY6 | |
| VTRSAGCGCCPMCAL | 51 | P08833 | |
| MDPNCSCEAGGSCAC | 1 | P80294 | |
| RILCADPCCQICNVM | 96 | A6NFA0 | |
| CCSHPCQNRGVCMSV | 21 | P35354 | |
| PGCGCCMTCALAEGQ | 51 | P24593 | |
| MELACQCPAVVCCRC | 746 | O75110 | |
| ACCLNAACMALVDAG | 131 | Q9NQT4 | |
| CDIPQCSEVECMTCN | 201 | P14210 | |
| GETRDACGCCPMCAR | 51 | Q16270 | |
| MDPNCSCSPVGSCAC | 1 | P80297 | |
| FGEMCEKCPTCPDAC | 621 | P18084 | |
| CCSCMCDEDNAAPQS | 91 | A6NMN3 | |
| VLFQPCGHMCACENC | 876 | Q86YT6 | |
| TCQLCGDRMSECPIC | 981 | Q86YT6 | |
| MCASFDSLPPCCCDI | 76 | Q8N5W8 | |
| MDPNCSCAAGDSCTC | 1 | P02795 | |
| DAMCCPGTLCVNDVC | 76 | Q9UBT3 | |
| TTMESCPSLQCCEGC | 71 | A6NFZ4 | |
| CPSLQCCEGCRMHAS | 76 | A6NFZ4 | |
| ESHDPCGCCNCMKAQ | 31 | Q9H819 | |
| MGCCPGDCFTCCTQE | 1 | Q9BYP8 | |
| HLLPQGCECCMSCAV | 1166 | Q86VF2 | |
| GCECCMSCAVQGSPR | 1171 | Q86VF2 | |
| GDVACMAICSCQCPA | 66 | Q9BRL7 | |
| MAICSCQCPAAMAFC | 71 | Q9BRL7 | |
| MDPNCSCAAGVSCTC | 1 | P04733 | |
| CAQMCQCPGENPACH | 1171 | O75095 | |
| AMCSACGLQAAVVCV | 256 | Q16831 | |
| MSLECGCAVCFKCIN | 51 | O75677 | |
| PHGEDLLCCCCSMVS | 71 | O75677 | |
| MAAQCCCRQAPGAEA | 1 | Q9HAU8 | |
| PMMLDCGHNICCACL | 26 | P14373 | |
| ACAECFMAVSCATCQ | 271 | Q8TF05 | |
| APCIQCLECCGMFAP | 286 | P12757 | |
| MCSARACPVACPVGC | 36 | O95177 | |
| DSCCICVCNMNIKGA | 1091 | Q9UHV7 | |
| VVMCSSACLACFCAN | 986 | Q9Y2K9 | |
| TGLTDCCNDMPVCLC | 26 | Q9BYD5 | |
| CCNDMPVCLCGTFAP | 31 | Q9BYD5 | |
| CLDSMCCFPEGEAAC | 1116 | Q9Y2G3 | |
| MQALTSCECTICPDC | 711 | Q96EP0 | |
| GCVMDENCQAGEKCC | 181 | Q8IUB2 | |
| MVCGGFACSKNCLCA | 1 | O95857 | |
| HAECPVSACTCKCMQ | 846 | Q9NXC5 | |
| MDPNCSCAAAGVSCT | 1 | P13640 | |
| CDSTCPCIMTQNFCE | 531 | Q92800 | |
| SCRDCAIDPTCVLCM | 111 | Q8IWV7 | |
| PMSLECGCAVCLKCI | 111 | O75678 | |
| PHGEDLLCCCCSMVS | 71 | O75679 | |
| ICMECKTGQHPCFSC | 741 | Q9BZ95 | |
| GFRCPQHCCSACSME | 791 | Q9BZ95 | |
| DCMCVQPEFHCGDPC | 71 | Q9Y5U5 | |
| CGISPCMSLCAECFH | 136 | Q6ZT12 | |
| VGVTCAACPFPCMND | 1786 | Q86YA3 | |
| CCQMCCGPFLLETPS | 396 | Q8N3G9 | |
| CFPCLGCQVAADMNE | 46 | Q9NZF1 | |
| GCQVAADMNECCLCG | 51 | Q9NZF1 | |
| LEEGCQTSPLMCCVC | 191 | P36406 | |
| RCGGCCNEESLICMN | 141 | O43915 | |
| SCVPLMRCGGCCNDE | 76 | P15692 | |
| SCPAMCTCSNGIVDC | 281 | O75093 | |
| SCRDCAVDPTCVLCM | 111 | Q8IWV8 | |
| HGAVGQEMCCPICCS | 586 | Q8NG27 | |
| VCICFIDDCMDCDVP | 2711 | Q5THJ4 | |
| CRSCCEGMICNVELP | 131 | Q8NI32 |